Compare CCK & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCK | FMS |
|---|---|---|
| Founded | 1906 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 13.6B |
| IPO Year | 2003 | 2005 |
| Metric | CCK | FMS |
|---|---|---|
| Price | $107.91 | $22.69 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 16 | 2 |
| Target Price | ★ $121.19 | $30.00 |
| AVG Volume (30 Days) | ★ 822.5K | 635.7K |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | 1.41% | ★ 2.57% |
| EPS Growth | ★ 79.72 | N/A |
| EPS | ★ 3.78 | N/A |
| Revenue | ★ $11,665,000,000.00 | N/A |
| Revenue This Year | $5.17 | N/A |
| Revenue Next Year | $2.38 | $3.83 |
| P/E Ratio | $27.96 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $89.21 | $20.02 |
| 52 Week High | $122.91 | $27.64 |
| Indicator | CCK | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 48.19 |
| Support Level | $97.66 | $22.37 |
| Resistance Level | $109.00 | $23.99 |
| Average True Range (ATR) | 2.26 | 0.28 |
| MACD | -0.54 | 0.05 |
| Stochastic Oscillator | 25.94 | 65.32 |
Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.